deltatrials
Completed NA INTERVENTIONAL 2-arm NCT03428997

Human Comedogenicity Test

Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)

Conditions Comedogenicity
Updated 12 times since 2018 Last updated: Jun 28, 2023 Started: Nov 20, 2017 Primary completion: Feb 5, 2018 Completion: Feb 5, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Comedogenicity and is currently completed. Johnson & Johnson Consumer Inc. (J&JCI) leads this study, which shows 12 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshotWithheld~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotWithheld~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshotWithheld~Jul 2018 – ~Sep 2019 · 14 months · monthly snapshotWithheld~Sep 2019 – ~Feb 2020 · 5 months · monthly snapshotCompleted~Feb 2020 – ~Dec 2020 · 10 months · monthly snapshotCompleted~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshotCompleted~Jan 2021 – ~Sep 2022 · 20 months · monthly snapshotCompleted~Sep 2022 – ~Aug 2023 · 11 months · monthly snapshotCompleted~Aug 2023 – ~Jul 2024 · 11 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

12 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Aug 2023 — Jul 2024 [monthly]

    Completed NA

  4. Sep 2022 — Aug 2023 [monthly]

    Completed NA

  5. Jan 2021 — Sep 2022 [monthly]

    Completed NA

Show 7 earlier versions
  1. Dec 2020 — Jan 2021 [monthly]

    Completed NA

  2. Feb 2020 — Dec 2020 [monthly]

    Completed NA

  3. Sep 2019 — Feb 2020 [monthly]

    Completed NA

    Status: WithheldCompleted · Phase: NoneNA

  4. Jul 2018 — Sep 2019 [monthly]

    Withheld

  5. Jun 2018 — Jul 2018 [monthly]

    Withheld

  6. Apr 2018 — Jun 2018 [monthly]

    Withheld

    Phase: NANone

  7. Mar 2018 — Apr 2018 [monthly]

    Withheld NA

    First recorded

Nov 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Johnson & Johnson Consumer Inc. (J&JCI)
Data source: Johnson & Johnson Consumer and Personal Products Worldwide

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations